Rockwell Medical, Inc.
RMTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $101,489 | $83,612 | $72,810 | $61,931 |
| % Growth | 21.4% | 14.8% | 17.6% | – |
| Cost of Goods Sold | $84,005 | $74,908 | $68,733 | $64,351 |
| Gross Profit | $17,484 | $8,704 | $4,077 | -$2,420 |
| % Margin | 17.2% | 10.4% | 5.6% | -3.9% |
| R&D Expenses | $19 | $1,107 | $3,119 | $6,835 |
| G&A Expenses | $14,108 | $12,142 | $15,644 | $15,348 |
| SG&A Expenses | $16,857 | $14,267 | $17,738 | $21,081 |
| Sales & Mktg Exp. | $2,749 | $2,125 | $2,094 | $5,733 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16,876 | $15,374 | $20,857 | $27,916 |
| Operating Income | $608 | -$6,670 | -$16,780 | -$30,336 |
| % Margin | 0.6% | -8% | -23% | -49% |
| Other Income/Exp. Net | -$1,088 | -$1,769 | -$1,899 | -$2,338 |
| Pre-Tax Income | -$480 | -$8,439 | -$18,679 | -$32,674 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$480 | -$8,439 | -$18,679 | -$32,674 |
| % Margin | -0.5% | -10.1% | -25.7% | -52.8% |
| EPS | -0.025 | -0.36 | -1.89 | -3.83 |
| % Growth | 93% | 81% | 50.7% | – |
| EPS Diluted | -0.025 | -0.36 | -1.89 | -3.83 |
| Weighted Avg Shares Out | 31,059 | 23,323 | 9,867 | 8,526 |
| Weighted Avg Shares Out Dil | 31,059 | 23,323 | 9,867 | 8,526 |
| Supplemental Information | – | – | – | – |
| Interest Income | $92 | $211 | $33 | $22 |
| Interest Expense | $1,254 | $2,301 | $1,936 | $2,360 |
| Depreciation & Amortization | $2,180 | $1,444 | $576 | $2,515 |
| EBITDA | $2,954 | -$4,694 | -$16,167 | -$27,799 |
| % Margin | 2.9% | -5.6% | -22.2% | -44.9% |